Ann: IHL-42X positive phase 2 clinical trial results, page-98

Still holding all my parcels (quite foolishly my trading one too) - and for the life of me can't figure out how the results are bad in any way. But let's not kid ourselves - they aren't good. The market never lies and someone smarter than us doesn't like them and this will close the gap at 51c or even go lower. And these aren't sell the news kind of fluff announcements like usually happens to IHL - this was a pivotal Phase II and it's getting railed.

Anyone got an inkling as to why they weren't good? Not patient numbers surely, we've covered that.